Ensysce Biosciences Debt-to-Assets Ratio Growth & History (ENSC)

Ensysce Biosciences's debt-to-assets ratio was 0.04 for fiscal 2025.

View full Ensysce Biosciences company overview

Ensysce Biosciences annual debt-to-assets ratio history

Ensysce Biosciences annual debt-to-assets ratio

Fiscal yearPeriod endedDebt-to-assets ratioChangeGrowth
20252025-12-310.04−0.01−23.64%
20242024-12-310.05−0.26−82.92%
20232023-12-310.320.31+6699.84%
20222022-12-310.000.00+206.34%
20212021-12-310.00−0.07−97.91%
20202020-12-310.07

Ensysce Biosciences debt-to-assets ratio trends

Over the last five fiscal years, Ensysce Biosciences's debt-to-assets ratio decreased from 0.07 to 0.04, a change of −0.03. The latest reported quarter, Q2 2026, shows 0.07.

About the metric

What the debt-to-assets ratio means

The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.

Calculation and source

How debt-to-assets is calculated

TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Ensysce Biosciences source filings ↗

Community posts

It’s quiet here.

No posts about ENSC yet. Start the conversation.

Write the first post